Evolution of the Average Target: Integra LifeSciences Holdings Corporation

Evolution of the Target Price: Integra LifeSciences Holdings Corporation

Changes in Analyst Recommendations: Integra LifeSciences Holdings Corporation

90bff6c14004e9.TcLwuUJH1pP3YntfaimG72j1u_cWEDg7oNZ-9t24vxY.BLCj3hgOmOSdITE-W3mzmjqq7qFORFpay5Adqe397WYZnZTXBR694ag0Tw~5d59aa7e636181973dbded258eea7790
07-30 BMO Cuts Price Target on Integra LifeSciences Holdings to $18 From $19, Keeps Market Perform Rating MT
07-28 UBS Initiates Coverage on Integra LifeSciences With Neutral Rating, $19 Price Target MT
07-16 Truist Adjusts Price Target on Integra LifeSciences Holdings to $19 From $14, Maintains Hold Rating MT
07-09 BMO Capital Initiates Integra LifeSciences at Market Perform With $19 Price Target MT
06-18 Integra LifeSciences Shares Rise After Upgrade From Argus Research MT
06-18 Argus Research Upgrades Integra LifeSciences to Buy From Hold, $25 Price Target MT
05-28 Citigroup Upgrades Integra LifeSciences to Neutral From Sell, Adjusts Price Target to $16 From $11 MT
05-06 Truist Adjusts Price Target on Integra LifeSciences to $14 From $12, Maintains Hold Rating MT
04-15 Truist Cuts Price Target on Integra LifeSciences Holdings to $12 From $13, Keeps Hold Rating MT
01-12 Canaccord Genuity Initiates Coverage on Integra LifeSciences With Speculative Buy Rating, CA$9.25 Price Target MT
31/07/25 Medtech firm Integra's Q2 revenue beats expectations RE
13/05/25 Morgan Stanley Adjusts Price Target on Integra LifeSciences Holdings to $10 From $20, Maintains Equalweight Rating MT
05/05/25 Top Midday Decliners MT
11/04/25 Truist Cuts Price Target on Integra LifeSciences Holdings to $19 From $26, Keeps Hold Rating MT
31/03/25 Argus Upgrades Integra LifeSciences to Buy From Hold, Price Target is $28 MT
05/11/24 Truist Raises Price Target on Integra LifeSciences Holdings to $26 From $21, Keeps Hold Rating MT
14/10/24 Correction: Truist Trims Price Target on Integra LifeSciences Holdings to $21 From $26, Keeps Hold Rating MT
14/10/24 Truist Raises Price Target on Integra LifeSciences Holdings to $26 From $21, Keeps Hold Rating MT
07/10/24 BTIG Upgrades Integra LifeSciences Holdings to Neutral From Sell MT
30/07/24 BTIG Downgrades Integra LifeSciences Holdings to Sell From Neutral, Price Target is $22 MT
30/07/24 Citigroup Downgrades Integra LifeSciences Holdings to Sell From Neutral, Adjusts Price Target to $23 From $30 MT
30/07/24 Analyst recommendations: 3M Company, Aon, Murphy USA, Skyworks, Tesla... Zonebourse
30/07/24 Truist Adjusts Price Target on Integra LifeSciences Holdings to $26 From $32 After 'Big' H2 Guide Cut, Maintains Hold Rating MT
16/07/24 Truist Raises Price Target on Integra LifeSciences Holdings to $32 From $25, Maintains Hold Rating MT
15/07/24 Morgan Stanley Raises Price Target on Integra LifeSciences to $27 From $24, Keeps Underweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+15.58%
+8.92%
+9.03%
+14.12%
+4.02%
+24.66%
+3.36%
+27.36%
+18.65%
+24.53%
Average +15.02%
Weighted average by Cap. +12.12%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
16.92USD
Average target price
19.56USD
Spread / Average Target
+15.58%
High Price Target
27.00USD
Spread / Highest target
+59.57%
Low Price Target
14.00USD
Spread / Lowest Target
-17.26%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. IART Stock
  4. Consensus Integra LifeSciences Holdings Corporation